Overview


Biotechnology is a cutting-edge, interdisciplinary field that uses biological systems, living organisms, or their derivatives, to develop or alter production processes or therapeutics. Biotechnology is the use of biological systems, living organisms, or parts thereof to create or develop various products. Due to technological advances, biotechnology has become simpler as an increasing number of market players create and launch new products to increase their market share. It has an impact on many industries including pharmaceuticals and medicine, genomics, and food and chemical production. Biotechnology plays an important and comprehensive role when it comes to addressing pressing environmental issues, energy and food security, as well as health and well-being.

Biotechnology is driven by the regulatory support provided by different governments, the rising food demand, the technological advances to combat severe diseases, and the depletion of natural resources. The biotechnology market is constrained in its growth by several factors, such as the long time it takes to commercialize research and the public's attitude towards biotech products. Innovative technology and the growing advances in life science are bringing many benefits to healthcare interventions. The biotech industry is expected to grow significantly as a result of the development and implementation of innovative technologies by companies.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Global Biotechnology Medicine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Global Biotechnology Medicine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Novo Nordisk A/S
  • Amgen
  • Regeneron Pharmaceuticals
  • Jazz Pharmaceuticals plc
  • Novavax, Inc.
  • Novartis
  • Pfizer
  • F. Hoffmann-La Roche AG
  • Biogen
  • Genentech
  • Vertex Pharmaceutical Inc
  • BioNTech SE
  • Incyte Corp
  • GlaxoSmithKline Plc
  • Biocon Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Application

  • Gene Therapy
  • Recombinant Insulin
  • Monoclonal Diagnostics
  • Vaccines
  • Pharmacogenomics
  • Others

By Diseases Type

  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Rare Diseases
  • Inflammatory Diseases
  • Others

By End-Use

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Academic & Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Global Biotechnology Medicine Market By Application, By Diseases Type, By End-Use, and Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Global Biotechnology Medicine Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Global Biotechnology Medicine Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Global Biotechnology Medicine Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Global Biotechnology Medicine Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Gene Therapy
        2. Recombinant insulin 
        3. Monoclonal Diagnostics
        4. Vaccines
        5. Pharmacogenomics
        6. Others

  • 8.  Global Biotechnology Medicine Market, By Diseases Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Cancer
        2. Cardiovascular Diseases
        3. Diabetes
        4. Rare Diseases
        5. Inflammatory Diseases
        6. Others

  • 9.  Global Biotechnology Medicine Market, By End-Use Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Academic & Research Institutes

  • 10.  North America Global Biotechnology Medicine Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.  Latin America Global Biotechnology Medicine Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.  Europe Global Biotechnology Medicine Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.  Asia Pacific Global Biotechnology Medicine Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 14.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Novo Nordisk A/S
            1.1. Company Overview
            1.2. Product Portfolio
            1.3. SWOT Analysis
            1.4. Financial Overview
            1.5. Strategic Overview
        2. Amgen
            2.1. Company Overview
            2.2. Product Portfolio
            2.3. SWOT Analysis
            2.4. Financial Overview
            2.5. Strategic Overview
        3. Regeneron Pharmaceuticals
            3.1. Company Overview
            3.2. Product Portfolio
            3.3. SWOT Analysis
            3.4. Financial Overview
            3.5. Strategic Overview
        4. Jazz Pharmaceuticals plc
            4.1. Company Overview
            4.2. Product Portfolio
            4.3. SWOT Analysis
            4.4. Financial Overview
            4.5. Strategic Overview
        5. Novavax, Inc.
            5.1. Company Overview
            5.2. Product Portfolio
            5.3. SWOT Analysis
            5.4. Financial Overview
            5.5. Strategic Overview
        6. Novartis
            6.1. Company Overview
            6.2. Product Portfolio
            6.3. SWOT Analysis
            6.4. Financial Overview
            6.5. Strategic Overview
        7. Pfizer
            7.1. Company Overview
            7.2. Product Portfolio
            7.3. SWOT Analysis
            7.4. Financial Overview
            7.5. Strategic Overview
        8. F. Hoffmann-La Roche AG
            8.1. Company Overview
            8.2. Product Portfolio
            8.3. SWOT Analysis
            8.4. Financial Overview
            8.5. Strategic Overview
        9. Biogen
            9.1. Company Overview
            9.2. Product Portfolio
            9.3. SWOT Analysis
            9.4. Financial Overview
            9.5. Strategic Overview
        10. Genentech
            10.1. Company Overview
            10.2. Product Portfolio
            10.3. SWOT Analysis
            10.4. Financial Overview
            10.5. Strategic Overview
        11. Vertex Pharmaceutical Inc
            11.1. Company Overview
            11.2. Product Portfolio
            11.3. SWOT Analysis
            11.4. Financial Overview
            11.5. Strategic Overview
        12. BioNTech SE
            12.1. Company Overview
            12.2. Product Portfolio
            12.3. SWOT Analysis
            12.4. Financial Overview
            12.5. Strategic Overview
        13. Incyte Corp
            13.1. Company Overview
            13.2. Product Portfolio
            13.3. SWOT Analysis
            13.4. Financial Overview
            13.5. Strategic Overview
        14. GlaxoSmithKline Plc
            14.1. Company Overview
            14.2. Product Portfolio
            14.3. SWOT Analysis
            14.4. Financial Overview
            14.5. Strategic Overview
        15. Biocon Ltd.
            15.1. Company Overview
            15.2. Product Portfolio
            15.3. SWOT Analysis
            15.4. Financial Overview
            15.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact
    •  1. Positive influence on the healthcare industry
       2. The financial disruption of the manufacturing sector
       3. Impact of COVID-19 on emerging companies
       4. Significant mandates in the healthcare regulations initiated
      by administrations
       5. The overall economic slowdown of the developing and developed nations

  • 18.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients